Colder Weather May Bring Added Discomfort For Raynaud's Sufferers PDF Print E-mail
Tuesday, 17 November 2009 14:02
taken from http://www.flickr.com/photos/denisecarbonell/3269836335/ via creative commonsColder weather triggers a painful and sometimes debilitating disorder for many who suffer from Raynaud's disease. Raynaud's is an autoimmune disorder in which spasms in the blood vessels can interrupt blood flow to the fingers, toes, nose and ears. Exposure to cold triggers the spasms, typically causing the affected area to turn white, then blue, then bright red. Emotional stress can also cause an attack.

During an attack, Raynaud's sufferers experience tingling, swelling or painful throbbing. Episodes may last from minutes to hours. In severe cases, the area may develop ulcerations and infections.

According to the Raynaud's Association, only one out of five sufferers seeks treatment. Both men and women suffer from Raynaud's, but women are nine times more likely to be affected. "Some researchers estimate as many as 20 percent of all women in their childbearing years have Raynaud's," says Lynn Wunderman, chair of the Raynaud's Association.

"Too many Raynaud's sufferers dismiss their symptoms as being due to 'poor circulation,'" Wunderman says. "In a sense that's true, but there's a medical cause for their poor circulation -- and sometimes it can be serious."

In some cases, Raynaud's symptoms may indicate a serious underlying disorder such as Scleroderma, lupus or rheumatoid arthritis. Robert Riggs, CEO of the Scleroderma Foundation, notes that more than 90 percent of people diagnosed with systemic scleroderma also have Raynaud's. "In most of these cases, Raynaud's is the first symptom."

These patients are considered to have "secondary Raynaud's," meaning another associated disease is present. Fortunately, however, most Raynaud's sufferers have the more benign "primary" form. The Raynaud's Association and the Scleroderma Foundation advise individuals with symptoms to consult with their physicians, who can perform simple blood tests to determine whether or not antibodies associated with other diseases are present. Rheumatologists -- physicians who specialize in the diagnosis and treatment of arthritis, Raynaud's and diseases of the joints, muscles and bones -- may be consulted.

At this time there is no cure for Raynaud's, although research is underway. In the meantime, sufferers are advised to avoid cold temperatures as much as possible, effect lifestyle changes and protect the affected extremities with gloves, hats and other such measures. "Obviously, winter presents the biggest challenges," says Wunderman. So, should Raynaud's sufferers move south for the winter? "Well," she concludes, "that might help somewhat, if you can avoid all of those frigid air conditioned places -- not an option for many sufferers in their daily lives."

This article was taken in part from the PR Newswire. For a link to the orginal  article, click here. To find out more about Raynaud's, click here for our previous article, and do visit the Raynaud's Association for more... and do remember to stay warm.
 
More articles :

» Oral Health of Chinese People with Systemic Sclerosis

Clive M. K. Yeung; Ian A. Lai; C. H. Chu; W. Keung Leung; Mo Yin MokThe University of Hong KongReceived: 22 July 2010 / Accepted: 28 September 2010 / Published online: 12 October 2010Scleroderma is a symptom of a group of diseases that involve the...

» Long-Term Outcomes of Scleroderma Renal Crisis

In a previous study. researchers sought to describe the medical history of a group of patients with Scleroderma Renal Crisis who had been treated with ACE inhibitors. The following is essentially a summary of that study, which was conducted by...

» Gastric Antral Vascular Ectasia in Systemic Sclerosis

Jill Johnson and Chris T. DerkReceived 9 June 2011; Accepted 26 August 2011Gastric antral vascular ectasia (GAVE) was first defined in 1984 by Jabbari et al. Its distinctive endoscopic appearance caused it to be also known as “watermelon...

» Scleroderma Drug In Development

According to , has partnered with , the health care investment arm of Morgan Keegan and Co. Inc., to jump-start a capital campaign to raise $12 million to $15 million. ArGentis shelved the campaign last year when the economy soured.The money will...

» Toll-like receptor 7 (TLR7)–Driven Accumulation of a Novel CD11c+ B-cell Population is Important for the Development of Autoimmunity

Anatoly V. Rubtsov, Kira Rubtsova, Aryeh Fischer, Richard T. Meehan, Joann Z. Gillis, John W. Kapple, and Philippa MarrackThe American Society of HematologyFemales are more susceptible than males to many autoimmune diseases. The processes causing...

» Real-World Bosentan Therapy Successful in Pulmonary Arterial Hypertension: Presented at ATS

Real-life experiences in treating patients with pulmonary arterial hypertension with bosentan appears to provide similar efficacy as seen in clinical trials -- despite patients being somewhat older and having more scleroderma, researchers said today...